Ben Lenail, based in Palo Alto CA, has consulted with biotech companies such as Minoryx Therapeutics, Autobahn Therapeutics, and Deep Genomics; and medical device companies Cionic and Flow Neuroscience. Ben is an investor in 40 early-stage healthcare companies with HealthTech Capital. He is Vice-Chair of the American Brain Foundation; a mentor with the Chan Zuckerberg Initiative; and serves on the Advisory Board of the UCSF Center for Vulnerable Populations.Ben has worked in high-tech in Silicon Valley for 30+ years. He’s a graduate of the University of Washington in Seattle WA and Sciences-Po in Paris. Ben’s wife Laurie Yoler has been his partner for 35 years.